generic semaglutide injection Canada approves from Dr. Reddy's, a G7 first enabled by Novo Nordisk's lapsed CAD$250 patent Dr. Reddy's says API issue
Description
These findings may suggest a systemic hypersensitivity reaction or other condition requiring evaluation
Meanwhile, Eli Lilly has issued a warning about compounded tirzepatide that may contain B12 or other additives
Why Its Important: Its changing the way we think of weight gain and obesity
Clinical studies show some great results
Plateaus are common and do not signal treatment failure
